Literature DB >> 6832193

Disposition kinetics of metronidazole in children.

I Amon, K Amon, H Scharp, G Franke, F Nagel.   

Abstract

The pharmacokinetics of metronidazole was studied in 20 paediatric patients aged 6 weeks and 4 to 14 years, who had trichomonal vaginitis or an anaerobic bacterial infection. The dosage of metronidazole was about 10 or 20 mg/kg b.i.d. orally. The serum concentrations found in children and the corresponding calculated kinetic parameters were similar to those in adults after intake of an equal, weight-related dose. Metronidazole shows rapid diffusion into the saliva with a concentration ratio of about 1.0. This can provide the basis for an efficient non-invasive method of drug monitoring.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832193     DOI: 10.1007/bf00613937

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Pharmacokinetics of metronidazole as determined by bioassay.

Authors:  E D Ralph; J T Clarke; R D Libke; R P Luthy; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

2.  [Pharmacokinetics in multiple dosage--2 examples].

Authors:  K E Biebler
Journal:  Z Arztl Fortbild (Jena)       Date:  1981-05-15

3.  Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose.

Authors:  G W Houghton; P S Thorne; J Smith; R Templeton; J Collier
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

4.  Comparative pharmacokinetic studies of ornidazole and metronidazole in man.

Authors:  D E Schwartz; F Jeunet
Journal:  Chemotherapy       Date:  1976       Impact factor: 2.544

5.  Anaerobic infection in a neonate. Early detection by gas liquid chromatography and response to metronidazole.

Authors:  S Rom; D Flynn; P Noone
Journal:  Arch Dis Child       Date:  1977-09       Impact factor: 3.791

6.  Binding of metronidazole and its derivatives to plasma proteins: an assessment of drug binding phenomenon.

Authors:  D R Sanvordeker; Y W Chien; T K Lin; H J Lambert
Journal:  J Pharm Sci       Date:  1975-11       Impact factor: 3.534

7.  Urinary tract infection caused by anaerobic bacteria in children.

Authors:  I Brook
Journal:  Urology       Date:  1980-12       Impact factor: 2.649

8.  Metronidazole prophylaxis for elective large bowel surgery in children: a prospective trial.

Authors:  O Khan; H H Nixon
Journal:  Br J Surg       Date:  1978-11       Impact factor: 6.939

Review 9.  Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

10.  Metronidazole, tinidazole, ornidazole and anaerobic infections of the middle ear, maxillary sinus and central nervous system.

Authors:  A M Jokipii; L Jokipii
Journal:  Scand J Infect Dis Suppl       Date:  1981
View more
  7 in total

1.  The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst.

Authors:  Robin E Pearce; Michael Cohen-Wolkowiez; Mario R Sampson; Gregory L Kearns
Journal:  Drug Metab Dispos       Date:  2013-06-27       Impact factor: 3.922

Review 2.  Pharmacokinetic studies in infants using minimal-risk study designs.

Authors:  Julie Autmizguine; Daniel K Benjamin; P Brian Smith; Mario Sampson; Philippe Ovetchkine; Michael Cohen-Wolkowiez; Kevin M Watt
Journal:  Curr Clin Pharmacol       Date:  2014

Review 3.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

4.  Plasma metronidazole concentrations after single and repeated vaginal pessary administration.

Authors:  I G Salas-Herrera; M Lawson; A Johnston; P Turner; D M Gott; M J Dennis
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

Review 5.  Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.

Authors:  A H Lau; N P Lam; S C Piscitelli; L Wilkes; L H Danziger
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

6.  Single dose prophylaxis with metronidazole in infants during abdominal surgery: a pharmacokinetic study.

Authors:  A Rubenson; A Rosetzsky
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Metronidazole excretion in human milk and its effect on the suckling neonate.

Authors:  C M Passmore; J C McElnay; E A Rainey; P F D'Arcy
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.